174 related articles for article (PubMed ID: 12173996)
1. Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritis.
Oğuz F; Akdeniz C; Unüvar E; Küçükbasmaci O; Sidal M
J Paediatr Child Health; 2002 Aug; 38(4):358-62. PubMed ID: 12173996
[TBL] [Abstract][Full Text] [Related]
2. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
Gonzalez B; Larrañaga C; León O; Díaz P; Miranda M; Barría M; Gaggero A
J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
[TBL] [Abstract][Full Text] [Related]
3. Acute human parvovirus B-19 infection in hospitalized children: A serologic and molecular survey.
Miron D; Luder A; Horovitz Y; Izkovitz A; Shizgreen I; Ben David E; Ohnona FS; Schlesinger Y
Pediatr Infect Dis J; 2006 Oct; 25(10):898-901. PubMed ID: 17006284
[TBL] [Abstract][Full Text] [Related]
4. [Seroprevalence of B19 parvovirus infection in patients with acute polyarthritis].
Campoy Reolid E; Casanova Rituerto A; Rodríguez Moreno J; Gómez Vaquero C; Ros Expósito S; Roig Escofet D
Rev Clin Esp; 1996 Dec; 196(12):828-30. PubMed ID: 9132859
[TBL] [Abstract][Full Text] [Related]
5. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy.
Söderlund M; von Essen R; Haapasaari J; Kiistala U; Kiviluoto O; Hedman K
Lancet; 1997 Apr; 349(9058):1063-5. PubMed ID: 9107245
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis.
Weissbrich B; Süss-Fröhlich Y; Girschick HJ
Arthritis Res Ther; 2007; 9(4):R82. PubMed ID: 17760961
[TBL] [Abstract][Full Text] [Related]
7. Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis.
Zakrzewska K; Azzi A; De Biasi E; Radossi P; De Santis R; Davoli PG; Tagariello G
J Med Virol; 2001 Oct; 65(2):402-7. PubMed ID: 11536251
[TBL] [Abstract][Full Text] [Related]
8. [A girl with systemic onset juvenile rheumatoid arthritis suspected to be due to human parvovirus B19 infection].
Wada Y; Kobayashi M; Kubo M
Kansenshogaku Zasshi; 1997 May; 71(5):468-73. PubMed ID: 9209130
[TBL] [Abstract][Full Text] [Related]
9. Different patterns of disease manifestations of parvovirus B19-associated reactive juvenile arthritis and the induction of antiphospholipid-antibodies.
Lehmann HW; Plentz A; von Landenberg P; Küster RM; Modrow S
Clin Rheumatol; 2008 Mar; 27(3):333-8. PubMed ID: 17851708
[TBL] [Abstract][Full Text] [Related]
10. Parvovirus-associated arthritis.
Moore TL
Curr Opin Rheumatol; 2000 Jul; 12(4):289-94. PubMed ID: 10910181
[TBL] [Abstract][Full Text] [Related]
11. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection.
Kerr JR; Bracewell J; Laing I; Mattey DL; Bernstein RM; Bruce IN; Tyrrell DA
J Rheumatol; 2002 Mar; 29(3):595-602. PubMed ID: 11911112
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of antihuman parvovirus B19 IgG antibodies in patients with refractory rheumatoid arthritis and polyarticular juvenile rheumatoid arthritis.
Mimori A; Misaki Y; Hachiya T; Ito K; Kano S
Rheumatol Int; 1994; 14(3):87-90. PubMed ID: 7839075
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
14. Is routine viral screening useful in patients with recent-onset polyarthritis of a duration of at least 6 weeks? Results from a nationwide longitudinal prospective cohort study.
Varache S; Narbonne V; Jousse-Joulin S; Guennoc X; Dougados M; Daurès JP; Devauchelle-Pensec V; Saraux A
Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1565-70. PubMed ID: 21954118
[TBL] [Abstract][Full Text] [Related]
15. Human parvovirus B19 infection in children: uncommon clinical presentations.
Barash J; Dushnitzky D; Sthoeger D; Bardenstein R; Barak Y
Isr Med Assoc J; 2002 Oct; 4(10):763-5. PubMed ID: 12389336
[TBL] [Abstract][Full Text] [Related]
16. Human parvovirus B19 in childhood acute lymphoblastic leukaemia in Basrah.
Ibrahem WN; Hasony HJ; Hassan JG
J Pak Med Assoc; 2014 Jan; 64(1):9-12. PubMed ID: 24605704
[TBL] [Abstract][Full Text] [Related]
17. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
[TBL] [Abstract][Full Text] [Related]
18. [Observations on human parvovirus B19 infection diagnosed in 2011].
Mihály I; Trethon A; Arányi Z; Lukács A; Kolozsi T; Prinz G; Marosi A; Lovas N; Dobner IS; Prinz G; Szalai Z; Pék T
Orv Hetil; 2012 Dec; 153(49):1948-57. PubMed ID: 23204301
[TBL] [Abstract][Full Text] [Related]
19. [Role of parvovirus B19 as a causative agent for arthritis in children -- preliminary studies].
Szumera M; Sikorska-Wiśniewska G; Szweda P; Korzon M
Med Wieku Rozwoj; 2004; 8(2 Pt 2):425-32. PubMed ID: 15849401
[TBL] [Abstract][Full Text] [Related]
20. Raised IgM antibodies to parvovirus B19 in juvenile rheumatoid arthritis.
Kishore J; Misra R; Gupta D; Ayyagari A
Indian J Med Res; 1998 Jan; 107():15-8. PubMed ID: 9529776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]